Sassi, H., Bayle, A., Verret, B., Smolenschi, C., Hollebecque, A., Aldea, M., Morfouace, M., Degaud, M., Suybeng, V., Angevin, E., Goldbarg, V., Badoual, C., André, F., Barlesi, F., Lacroix, L., Caron, O., Vasseur, D., Italiano, A., Rouleau, E. (2026). cfDNA sequencing as a cutting-edge technology to identify pathogenic germline variants from 8353 patients with advanced tumors at the Gustave Roussy Institute.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3061